GENERIC NAME OF THE MEDICINAL PRODUCT:

a) Beclomethasone Dipropionate + Formoterol Fumarate Inhaler 100+6mcg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Beclomethasone Dipropionate + Formoterol Fumarate Inhaler 100+6mcg
Each actuation delivers
Fluticasone Propionate IP………….250 mcg
Formaterol Fumarate
Dihydrate IP……………………………….6 mcg
Suspended in
propellant HFA 1340

THERAPEUTIC INDICATIONS:

Beclometasone/formoterol, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled.

CAUTION & SCHEDULE:

CAUTION: Keep away from eyes. Keep away from children
Pressurised canister keep away from heat and light.
.do not puncture, break or burn. Do not exceed the recommended dose
SCHEDULE:Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store below 30 degree Celsius.
No Moisture
Dosage: See package insert for dosage information.
As directed by Physician

Beclomethasone Dipropionate + Formoterol Fumarate Inhaler 100+6mcg Technical Specification:

Product Name:Beclomethasone Dipropionate + Formoterol Fumarate Inhaler
Brand Name:Generics
Strength:100+6mcg
Dosage Form:Inhalers
Packing:120 Metered Dose
Route of Administration:Drugs administered by inhalation through the mouth.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Bronchodilators + Corticosteroids
Indication: Beclometasone/formoterol, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled.
Storage:Store below 30 degree Celsius.No Moisture and do not freeze.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Beclomethasone Dipropionate + Formoterol Fumarate Inhaler 100+6mcg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Beclomethasone Dipropionate + Formoterol Fumarate Inhaler 100+6mcg
    Each actuation delivers
    Fluticasone Propionate IP………….250 mcg
    Formaterol Fumarate
    Dihydrate IP……………………………….6 mcg
    Suspended in
    propellant HFA 1340

THERAPEUTIC INDICATION:

Beclometasone/formoterol, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled.

CAUTION & SCHEDULE:

CAUTION:Keep away from eyes. Keep away from children
Pressurised canister keep away from heat and light.
Do not puncture, break or burn. Do not exceed the recommended dose.
SCHEDULE:Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

Storage:Store below 30 degree Celsius.
No Moisture.
Dosage:See package insert for dosage information.
As directed by Physician.